Reviving Eyeballs: The Future of Eye Transplants with Perfusion Technology

A groundbreaking device using perfusion technology could revolutionize eye transplants by preserving and reviving donor eyeballs.

AATMA Team
AATMA Team
·4 min read
Researchers have developed a device called the Eye-in-a-Care-Box (ECaBox) that uses perfusion to maintain and revive eyeballs from deceased donors, potentially making whole-eye transplants viable. This innovation could transform the field of ophthalmology and organ transplantation by addressing the challenges of rapid degeneration in donor eyes.

The Challenge of Eye Transplants

Transplanting a whole human eye has long been a daunting challenge in the medical field. The complexity of the surgery is compounded by the rapid degeneration of eyeballs once they are removed from the body. Previous attempts at eye transplants have failed to restore vision, as the transplanted eyes were non-functional. However, a new device developed by researchers promises to change this narrative by preserving and reviving eyeballs, making eye transplants a realistic possibility.

The Eye-in-a-Care-Box (ECaBox): A Revolutionary Solution

The key to this breakthrough is a device called the Eye-in-a-Care-Box (ECaBox), which uses a technique known as perfusion. Perfusion involves supplying surgically removed organs with oxygen and nutrients, mimicking the environment inside the body. This process prevents the rapid degradation of the organs and preserves their functionality. In the case of the ECaBox, the device delivers an oxygen-rich fluid through the artery that normally supplies blood to the eye, keeping it viable for longer periods.

The ECaBox is designed with a sealed chamber that maintains a specific temperature and pressure, while a clear window allows researchers to study and image the eye during the process. This setup not only preserves the eyeball but also enables scientists to monitor its condition in real time.

Success with Pig Eyes

The team behind the ECaBox, led by Pia Cosma at the Centre for Genomic Regulation in Spain, initially tested the device on pig eyes, which are anatomically similar to human eyes but more accessible. Pig eyes left at room temperature quickly deteriorated, with cells shrinking and the structure of the eyes breaking down. Even when cooled to 4 °C (39 °F), the eyes degenerated within 24 hours.

However, pig eyes maintained in the ECaBox showed remarkable results. After 24 hours, the perfused eyes were significantly more viable than untreated eyes. Even more impressively, the perfused eyes regained the ability to respond to light within 15 minutes of treatment, a function lost immediately upon removal from the animal. Some treated eyes remained functional for over 10 hours.

Human Eye Trials

Encouraged by their success with pig eyes, the researchers moved on to human eyes. They collected 12 eyes from six deceased donors, treating one eye from each pair with the ECaBox while leaving the other untreated. The perfused eyes fared better, with their retinas remaining intact and preserved.

This breakthrough could pave the way for whole-eye transplants, a procedure that has had limited success in the past. For instance, in 2023, a team at NYU Langone performed a partial face and eye transplant on a man who had lost part of his face and eye in an accident. While the transplant was successful in terms of reconstruction, the transplanted eye did not restore vision.

The Future of Eye Transplants

The ECaBox represents a significant step forward in the field of eye transplants. By preserving donor eyeballs and potentially restoring their functionality, the device could make whole-eye transplants a viable treatment option for individuals with severe eye injuries or conditions. However, the true potential of the ECaBox will only be realized once transplants are attempted with treated eyes.

In the meantime, Cosma and her team are working on a portable version of the ECaBox that can be used in operating rooms to minimize degradation in donor eyes from heart-beating donors. This advancement could further improve the chances of successful eye transplants and expand the availability of donor eyes for research and treatment.

Beyond Transplants: Research Opportunities

The ECaBox also offers exciting possibilities for eye research. By providing a way to study and experiment on human eyes without relying on living animals, the device could accelerate the development of new treatments for eye diseases and conditions. This could lead to better outcomes for patients and advance the field of ophthalmology as a whole.

Conclusion

The Eye-in-a-Care-Box is a groundbreaking innovation that has the potential to transform the field of eye transplants. By preserving and reviving donor eyeballs, the device addresses one of the biggest challenges in ophthalmology. As research continues, the ECaBox could open the door to successful whole-eye transplants, offering hope to millions of people worldwide who suffer from vision loss or eye-related conditions.